Summary
The clastogenic effect of the anthracycline antitumor antibiotics, N,N-dimethyldaunomycin and aclacinomycin A, was studied in a murine hemopoietic cell line (Friend leukemia cells). A dose-dependent increase in chromatid lesions, i.e., achromatic lesions, chromatid breaks, chromatid deletions and triradial or quadriradial chromosomal exchange figures, was found. It appears that the clastogenicity of N,N-dimethyldaunomycin and aclacinomycin A is lower than that of the classic anthracycline, daunomycin, which is also a potent mutagen and carcinogen. The data demonstrate that the capacity of chemicals to induce point mutations and chromosomal aberrations may not necessarily be correlated: aclacinomycin A is devoid of mutagenic activity in bacterial (Salmonella typh.) and mammalian cell (HGPRT) mutagenesis assays, and is non-carcinogenic in rats. Nevertheless, it was now found to possess clastogenic activity.
References
Westendorf, J., Marquardt, H., and Marquardt, H., in: Anthracycline Antibiotics in Cancer Therapy, Developments in Oncology, vol. 10, pp. 30–49. Eds F.A. Muggia, C.W. Young and S. Carter. M. Nijhoff Publishers, The Hague 1982.
Vig, B.K., Mutat. Res.49 (1977) 189.
Westendorf, J., Marquardt, H., and Marquardt, H., Cancer Res.44 (1984) 5599.
Umezawa, K., Sawamura, M., Matsushima, T., and Sugimura, T., Cancer Res.38 (1978) 1782.
Westendorf, J., Groth, G., Steinheider, G., and Marquardt, H., Cell Biol. Toxic.1 (1985) 87.
Schwartz, E.L., and Sartorelli, A.C., Cancer Res.42 (1982) 2651.
Steinheider, G., and Kruse, S., Naunyn-Schmiedebergs Arch. Pharmak.329, suppl. (1985) R28.
Steinheider, G., Westendorf, J., and Marquardt, H., Leuk. Res.10 (1986) 1233.
Sakurai, M., Sampi, K., and Hozumi, M., Leuk. Res.7 (1983) 139.
Westendorf, J., Marquardt, H., Ketkar, M.B., Mohr, U., and Marquardt, H., Cancer Res.43 (1983) 5248.
Ostertag, W., Melderis, H., Steinheider, G., Kluge, N., and Dube, S.K., Nature, New Biol.239 (1972) 231.
Ostertag, W., and Pragnell, I.B., Curr. Topics Microbiol. Immun.94/95 (1981) 143.
Bender, M.A., Griggs, H.G., and Bedford, J.S., Mutat. Res.23 (1974) 197.
Steinheider, G., and Haase, S., Naunyn-Schmiedebergs Arch. Pharmak.332, suppl. (1986) R22.
Di Marco, A., and Arcamone, F., Arzneimittel-Forsch.25 (1975) 368.
Crooke, S.T., Duvernay, V.H., Galvan, L., and Prestayko, A.W., Molec. Pharmac.14 (1978) 290.
Young, R.C., Ozols, R.F., and Myers, C.E., New Engl. J. Med.305 (1981) 139.
Bachur, N.R., Gordon, S.L., and Gee, M.V., Cancer Res.38 (1978) 1745.
Nelson, E.M., Tewey, K.M., and Liu L.F., Proc. natn. Acad. Sci. USA81 (1984) 1361.
Tewey, K.M., Rowe, T.C., Yang, L., Halligan, B.D., and Liu, L.F., Science226 (1984) 466.
Pommier, Y., Zwelling, L.A., Kao-Shan, C., Whang-Peng, I., and bradley, M.D., Cancer Res.45 (1985) 3134.
Oki, T., Takeuchi, T., Oka, S., and Umezawa, H., Rec. Results Cancer Res.74 (1980) 207.
Schütte, I., Niederle, N., and Seeber, S., J. Cancer Res. clin. Oncol.105 (1983) 162.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Steinheider, G., Westendorf, J. & Marquardt, H. Induction of chromosomal aberrations by the anthracycline antitumor antibiotics N,N-dimethyldaunomycin and aclacinomycin A. Experientia 43, 586–588 (1987). https://doi.org/10.1007/BF02143595
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02143595